메뉴 건너뛰기




Volumn 11, Issue 2, 2007, Pages 289-298

Role of homologous recombination repair and non-homologous end joining in therapeutic resistance of BCR/ABL-expressing leukemia cells

Author keywords

BCR ABL; DNA repair; Drug resistance; Leukemia; STI571

Indexed keywords


EID: 41449089445     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (49)
  • 1
    • 0032546266 scopus 로고    scopus 로고
    • Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: Protection is correlated with up regulation of Bcl-xL
    • Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR (1998a) Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. Oncogene 16, 1383-1390.
    • (1998) Oncogene , vol.16 , pp. 1383-1390
    • Amarante-Mendes, G.P.1    McGahon, A.J.2    Nishioka, W.K.3    Afar, D.E.4    Witte, O.N.5    Green, D.R.6
  • 2
    • 0032032270 scopus 로고    scopus 로고
    • Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3
    • Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K (1998b) Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 91, 1700-1705.
    • (1998) Blood , vol.91 , pp. 1700-1705
    • Amarante-Mendes, G.P.1    Naekyung Kim, C.2    Liu, L.3    Huang, Y.4    Perkins, C.L.5    Green, D.R.6    Bhalla, K.7
  • 3
    • 0028910894 scopus 로고
    • The single cell gel electrophoresis assay for induced DNA damage (comet assay): Measurement of tail length and moment
    • Ashby JA, Tinwell H, Lefevre PA, Browne MA (1995) The single cell gel electrophoresis assay for induced DNA damage (comet assay): Measurement of tail length and moment. Mutagenesis 10, 85-90.
    • (1995) Mutagenesis , vol.10 , pp. 85-90
    • Ashby, J.A.1    Tinwell, H.2    Lefevre, P.A.3    Browne, M.A.4
  • 4
    • 0029131231 scopus 로고
    • BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents
    • Bedi A, Barber JP, Bedi GC, El-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood, 86, 1148-1158.
    • (1995) Blood , vol.86 , pp. 1148-1158
    • Bedi, A.1    Barber, J.P.2    Bedi, G.C.3    El-Deiry, W.S.4    Sidransky, D.5    Vala, M.S.6    Akhtar, A.J.7    Hilton, J.8    Jones, R.J.9
  • 7
    • 0030031766 scopus 로고    scopus 로고
    • Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
    • Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon HB (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56, 100-104.
    • (1996) Cancer Res , vol.56 , pp. 100-104
    • Buchdunger, E.1    Zimmermann, J.2    Mett, H.3    Meyer, T.4    Muller, M.5    Druker, B.J.6    Lydon, H.B.7
  • 9
    • 24044548990 scopus 로고    scopus 로고
    • Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants
    • Corradini F, Cesi V, Bartella V, Pani E, Bussolari R, Candini O, Calabretta B (2005) Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants. J Biol Chem 280, 30254-30262.
    • (2005) J Biol Chem , vol.280 , pp. 30254-30262
    • Corradini, F.1    Cesi, V.2    Bartella, V.3    Pani, E.4    Bussolari, R.5    Candini, O.6    Calabretta, B.7
  • 10
    • 0025117392 scopus 로고
    • Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein
    • Daley GQ, Van Etten RA, Baltimore D (1990) Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein. Science 247, 824-830.
    • (1990) Science , vol.247 , pp. 824-830
    • Daley, G.Q.1    Van Etten, R.A.2    Baltimore, D.3
  • 12
    • 0041466445 scopus 로고    scopus 로고
    • Specific targeted therapy of chronic myelogenous leukemia with imatinib
    • Deininger MW, Druker BJ (2003) Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev 55, 401-423.
    • (2003) Pharmacol Rev , vol.55 , pp. 401-423
    • Deininger, M.W.1    Druker, B.J.2
  • 13
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR/ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001b) Activity of a specific inhibitor of the BCR/ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344, 1038-1042.
    • (2001) N Engl J Med , vol.344 , pp. 1038-1042
    • Druker, B.J.1    Sawyers, C.L.2    Kantarjian, H.3    Resta, D.J.4    Reese, S.F.5    Ford, J.M.6    Capdeville, R.7    Talpaz, M.8
  • 16
    • 0038172523 scopus 로고    scopus 로고
    • Chronic myeloid leukemia in the imatinib era
    • Druker BJ (2003) Chronic myeloid leukemia in the imatinib era. Semin Hematol 40, 50-58.
    • (2003) Semin Hematol , vol.40 , pp. 50-58
    • Druker, B.J.1
  • 17
    • 0028264824 scopus 로고
    • Modelling the process of drug resistance
    • Goldie JH (1994) Modelling the process of drug resistance. Lung Cancer 10, 91-96.
    • (1994) Lung Cancer , vol.10 , pp. 91-96
    • Goldie, J.H.1
  • 18
    • 28544450495 scopus 로고    scopus 로고
    • Selecting and deselecting imatinib-resistant clones: Observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
    • Gruber FX, Lamark T, Anonli TA, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005) Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL. Leukemia 19, 2159-2165.
    • (2005) Leukemia , vol.19 , pp. 2159-2165
    • Gruber, F.X.1    Lamark, T.2    Anonli, T.A.3    Sovershaev, M.A.4    Olsen, M.5    Gedde-Dahl, T.6    Hjort-Hansen, H.7    Skogen, B.8
  • 20
    • 0028889948 scopus 로고
    • Molecular mechanisms of drug resistance in tumours
    • Harrison DJ (1995) Molecular mechanisms of drug resistance in tumours. J Pathol, 175, 7-12.
    • (1995) J Pathol , vol.175 , pp. 7-12
    • Harrison, D.J.1
  • 22
    • 0344951307 scopus 로고    scopus 로고
    • Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: Role in drug resistance?
    • Hoser G, Majsterek I, Romana DL, Slupianek A, Blasiak J, Skorski T ( 2003) Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: role in drug resistance? Leukemia Res 27, 267-273.
    • (2003) Leukemia Res , vol.27 , pp. 267-273
    • Hoser, G.1    Majsterek, I.2    Romana, D.L.3    Slupianek, A.4    Blasiak, J.5    Skorski, T.6
  • 23
    • 0030580947 scopus 로고    scopus 로고
    • The comet assay: Mechanisms and technical considerations
    • Klaude M, Eriksson S, Nygren J, Ahnstrom G (1996) The comet assay: mechanisms and technical considerations. Mutat Res 12, 89-96.
    • (1996) Mutat Res , vol.12 , pp. 89-96
    • Klaude, M.1    Eriksson, S.2    Nygren, J.3    Ahnstrom, G.4
  • 24
    • 0037672877 scopus 로고    scopus 로고
    • Philadelphia chromosome-positive leukemias: From basic mechanisms to molecular therapeutics
    • Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M (2003) Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Int Med 138, 819-830.
    • (2003) Ann Int Med , vol.138 , pp. 819-830
    • Kurzrock, R.1    Kantarjian, H.M.2    Druker, B.J.3    Talpaz, M.4
  • 25
    • 41449104648 scopus 로고    scopus 로고
    • 1 expression in a leukemia cell line and its doxorubicine-resistant variant by topoisomerase II inhibitors
    • 1 expression in a leukemia cell line and its doxorubicine-resistant variant by topoisomerase II inhibitors. Biochemical Pharmacology 60, 1832-1828.
    • (2000) Biochemical Pharmacology , vol.60 , pp. 1832-1828
    • Laroche-Clary, A.1    Larrue, A.2    Robert, J.3
  • 26
    • 15844385545 scopus 로고    scopus 로고
    • Ku80-deficient cells exhibit excess degradation of Extrachromosomal DNA
    • Liang F, Jasin M (1996) Ku80-deficient cells exhibit excess degradation of Extrachromosomal DNA. J Biol Chem 271, 14405-14411.
    • (1996) J Biol Chem , vol.271 , pp. 14405-14411
    • Liang, F.1    Jasin, M.2
  • 27
    • 0025348013 scopus 로고
    • Tyrosine kinse activity and transformation potency of BCR/ABL oncogene products
    • Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990) Tyrosine kinse activity and transformation potency of BCR/ABL oncogene products. Science 247, 1079-1082.
    • (1990) Science , vol.247 , pp. 1079-1082
    • Lugo, T.G.1    Pendergast, A.M.2    Muller, A.J.3    Witte, O.N.4
  • 28
    • 0036343687 scopus 로고    scopus 로고
    • Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?
    • Majsterek I, Blasiak J, Mlynarski W, Hoser G, Skorski T (2002) Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells? Cell Biol Int 26, 363-370.
    • (2002) Cell Biol Int , vol.26 , pp. 363-370
    • Majsterek, I.1    Blasiak, J.2    Mlynarski, W.3    Hoser, G.4    Skorski, T.5
  • 29
    • 0142093206 scopus 로고    scopus 로고
    • TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin
    • Majsterek I, Slupianek A, Blasiak J (2003) TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin. Anti-Cancer Drugs 14, 625-631.
    • (2003) Anti-Cancer Drugs , vol.14 , pp. 625-631
    • Majsterek, I.1    Slupianek, A.2    Blasiak, J.3
  • 30
    • 1342308086 scopus 로고    scopus 로고
    • ABL-fusion oncoproteins activate multi-pathway of DNA repair: Role in drug resistance?
    • Majsterek I, Slupianek A, Hoser G, Skorski T, Blasiak J (2004) ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance? Biochemie 86, 53-65.
    • (2004) Biochemie , vol.86 , pp. 53-65
    • Majsterek, I.1    Slupianek, A.2    Hoser, G.3    Skorski, T.4    Blasiak, J.5
  • 31
    • 0032924293 scopus 로고    scopus 로고
    • Masumoto N, Nakano S, Fujishima H, Kohno K, Niho Y (1999) v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells Int J Cancer 80, 731-737.
    • Masumoto N, Nakano S, Fujishima H, Kohno K, Niho Y (1999) v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells Int J Cancer 80, 731-737.
  • 32
    • 0036139993 scopus 로고    scopus 로고
    • STI571: A paradigm of new agents for cancer therapeutics
    • Mauro MJ, O'Dwyer M, Heinrich MC, Druker BJ (2002) STI571: a paradigm of new agents for cancer therapeutics. Clin Oncol 20, 325-334.
    • (2002) Clin Oncol , vol.20 , pp. 325-334
    • Mauro, M.J.1    O'Dwyer, M.2    Heinrich, M.C.3    Druker, B.J.4
  • 33
    • 0036682301 scopus 로고    scopus 로고
    • Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)
    • Nagar B, Bornmann WG, Pellicena P, Schindler T, Veach DR, Miller WT, Clarkson B, Kuriyan J (2002) Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res 62, 4236-4243.
    • (2002) Cancer Res , vol.62 , pp. 4236-4243
    • Nagar, B.1    Bornmann, W.G.2    Pellicena, P.3    Schindler, T.4    Veach, D.R.5    Miller, W.T.6    Clarkson, B.7    Kuriyan, J.8
  • 37
    • 0028200221 scopus 로고
    • Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
    • Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ ( 1994) Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells, Oncogene 9, 1829-1838.
    • (1994) Oncogene , vol.9 , pp. 1829-1838
    • Pietras, R.J.1    Fendly, B.M.2    Chazin, V.R.3    Pegram, M.D.4    Howell, S.B.5    Slamon, D.J.6
  • 38
    • 0031946385 scopus 로고    scopus 로고
    • Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
    • Sattler M, Salgia R (1998) Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Leukemia 12, 637-644.
    • (1998) Leukemia , vol.12 , pp. 637-644
    • Sattler, M.1    Salgia, R.2
  • 39
    • 0031840440 scopus 로고    scopus 로고
    • Structural Requirements for Function of the Crkl Adapter Protein in Fibroblasts and Hematopoietic Cells
    • Senechal K, Heaney C, Druker B, Sawyers CL (1998) Structural Requirements for Function of the Crkl Adapter Protein in Fibroblasts and Hematopoietic Cells. Mol Cell Biol 18, 5082-5090.
    • (1998) Mol Cell Biol , vol.18 , pp. 5082-5090
    • Senechal, K.1    Heaney, C.2    Druker, B.3    Sawyers, C.L.4
  • 40
    • 0023919963 scopus 로고
    • A simple technique for quantitation of low levels of DNA damage in individual cells
    • Singh NP, McCoy T, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175, 184-192.
    • (1988) Exp Cell Res , vol.175 , pp. 184-192
    • Singh, N.P.1    McCoy, T.2    Tice, R.R.3    Schneider, E.L.4
  • 41
    • 0000507213 scopus 로고    scopus 로고
    • Differential responses of proliferating versus quiescent cells to adriamycin
    • Siu WY, Arooz T, Poon RYC (1999) Differential responses of proliferating versus quiescent cells to adriamycin. Exp Cell Res 250, 131-141.
    • (1999) Exp Cell Res , vol.250 , pp. 131-141
    • Siu, W.Y.1    Arooz, T.2    Poon, R.Y.C.3
  • 43
    • 0036261727 scopus 로고    scopus 로고
    • Fusion tyrosine kinases induce therapeutic drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase and protection from apoptosis
    • Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, Fishel R, Skorski T (2002) Fusion tyrosine kinases induce therapeutic drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase and protection from apoptosis. Mol Cell Biol 22, 4189-4201.
    • (2002) Mol Cell Biol , vol.22 , pp. 4189-4201
    • Slupianek, A.1    Hoser, G.2    Majsterek, I.3    Bronisz, A.4    Malecki, M.5    Blasiak, J.6    Fishel, R.7    Skorski, T.8
  • 44
    • 30344461008 scopus 로고    scopus 로고
    • BCR/ABL modifies the kinetics and fidelity of DNA double-strand break repair in hematopoetic cells
    • Slupianek A, Nowicki MO, Koptyra M, Skorski T (2006) BCR/ABL modifies the kinetics and fidelity of DNA double-strand break repair in hematopoetic cells. DNA Repair 5, 243-250.
    • (2006) DNA Repair , vol.5 , pp. 243-250
    • Slupianek, A.1    Nowicki, M.O.2    Koptyra, M.3    Skorski, T.4
  • 46
    • 0038700985 scopus 로고    scopus 로고
    • Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies
    • Tipping AJ, Melo JV (2003) Imatinib mesylate in combination with other chemotherapeutic drugs: in vitro studies. Semin. Hematol 40, 83-91.
    • (2003) Semin. Hematol , vol.40 , pp. 83-91
    • Tipping, A.J.1    Melo, J.V.2
  • 48
    • 10344225622 scopus 로고    scopus 로고
    • Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein
    • Yin T, Wu YL, Sun HP, Sun GL, Du YZ, Wang KK, Zhang J, Chen GQ, Chen SJ, Chen Z (2004) Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood 104, 4219-4225.
    • (2004) Blood , vol.104 , pp. 4219-4225
    • Yin, T.1    Wu, Y.L.2    Sun, H.P.3    Sun4    GL, D.Y.5    Wang, K.K.6    Zhang, J.7    Chen, G.Q.8    Chen, S.J.9    Chen, Z.10
  • 49
    • 0141799739 scopus 로고    scopus 로고
    • Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro
    • Zhang P, Gao WY, Turner S, Ducatman BS (2003) Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Mol Cancer 2, 1.
    • (2003) Mol Cancer , vol.2 , pp. 1
    • Zhang, P.1    Gao, W.Y.2    Turner, S.3    Ducatman, B.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.